Healthcare -
Biotechnology - NASDAQ - US
$ 4.73
1.94 %
$ 402 M
Market Cap
-4.01
P/E
TERN - STOCK-BASED COMPENSATION
Stock-based Compensation TERN - Terns Pharmaceuticals, Inc.
25.5 M
LAST VALUE
77.05%
2 YEAR CAGR
155.62%
5 YEAR CAGR
0.00%
10 YEAR CAGR